Update οn the diagnosis and management of systemic lupus erythematosus.
Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT.
Ann Rheum Dis. 2021 Jan;80(1):14-25. doi: 10.1136/annrheumdis-2020-218272. Epub 2020 Oct 13.
Childhood nephrotic syndrome.
Vivarelli M, Gibson K, Sinha A, Boyer O.
Lancet. 2023 Sep 2;402(10404):809-824. doi: 10.1016/S0140-6736(23)01051-6.
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Rovin BH, Teng YKO, Ginzler EM, Arriens C, Caster DJ, Romero-Diaz J, Gibson K, Kaplan J, Lisk L, Navarra S, Parikh SV, Randhawa S, Solomons N, Huizinga RB.
Lancet. 2021 May 29;397(10289):2070-2080. doi: 10.1016/S0140-6736(21)00578-X. Epub 2021 May 7.
Calcineurin inhibitor nephrotoxicity.
Naesens M, Kuypers DR, Sarwal M.
Clin J Am Soc Nephrol. 2009 Feb;4(2):481-508. doi: 10.2215/CJN.04800908.
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis.
Barrera-Chimal J, Girerd S, Jaisser F.
Kidney Int. 2019 Aug;96(2):302-319. doi: 10.1016/j.kint.2019.02.030. Epub 2019 Mar 13.
EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update.
Fanouriakis A, Kostopoulou M, Anders HJ, Andersen J, Aringer M, Beresford MW, Doria A, Frangou E, Furie R, Gladman DD, Houssiau F, Karras A, Kouloumas M, Madenidou AV, Malvar A, Marinaki S, Mok CC, Moroni G, Parodis I, Rednic S, Santos CS, Scire CA, Smolen JS, Tamirou F, Tanaka Y, Teng YKO, Welin E, Bertsias G, Boumpas DT.
Ann Rheum Dis. 2026 Jan;85(1):75-90. doi: 10.1016/j.ard.2025.09.007. Epub 2025 Oct 16.
Exploratory calcineurin inhibitor-free regimens in living-related kidney transplant recipients.
Garcia R, Machado PG, Felipe CR, Park SI, Spinelli GA, Franco MF, Tedesco-Silva H Jr, Medina-Pestana JO.
Braz J Med Biol Res. 2007 Apr;40(4):457-65. doi: 10.1590/s0100-879x2007000400003.
Chronic Kidney Disease After Liver Transplantation.
Cabeza Rivera FH, Concepcion BP, Levea SL.
Adv Kidney Dis Health. 2023 Jul;30(4):368-377. doi: 10.1053/j.akdh.2023.07.004.
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children.
Floege J, Gibson KL, Vivarelli M, Liew A, Radhakrishnan J, Balk EM, Gordon CE, Adam G, Tonelli M, Earley A, Rovin BH.
Kidney Int. 2025 May;107(5):806-808. doi: 10.1016/j.kint.2024.11.006.
A broad clinical spectrum of PLCepsilon1-related kidney disease and intrafamilial variability.
Yılmaz EK, Saygili S, Gulhan B, Canpolat N, Bayazıt AK, Kilic BD, Akıncı N, Benzer M, Goknar N, Tufan AK, Kalyoncu M, Nalcacioglu H, Tekcan D, Yıldız G, Agbas A, Nayır A, Topaloglu R, Caliskan S, Ozaltin F.
Pediatr Nephrol. 2022 Aug;37(8):1855-1866. doi: 10.1007/s00467-021-05371-7. Epub 2022 Jan 16.
